Coverage
-
October 01, 2012
A New Jersey federal judge on Monday invalidated the remaining patent in Hoffmann-La Roche Inc.'s consolidated lawsuits against Apotex Inc., Mylan Inc. and other generic drugmakers over the osteoporosis drug Boniva, issuing an unprompted ruling that the bone treatment is obvious.
1 other articles on this case.
View all »